Oruka Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -19 | -16 | |
EBITDA | -30,257 | -24,555 | -20,983 |
EBIT | -30,277 | -24,574 | -20,999 |
Net Income | -30,277 | -24,574 | -20,999 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -21,701 | -23,179 | -20,882 |
Cash | 91,253 | 65,396 | 83,572 |
Basic Shares | 44,067 | 42,233 | 41,679 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Gross Profit | -27 | -111 | -114 | -91 |
EBITDA | -82,229 | -5,228 | -9,812 | -19,231 |
EBIT | -82,256 | -5,339 | -9,926 | -19,322 |
Net Income | -83,724 | -5,339 | -9,926 | -19,322 |
Free Cash Flow | -58,026 | -10,914 | -18,805 | |
Cash | 61,575 | 37,431 | 42,445 | 53,359 |
Basic Shares | 16,789 | 14,415 | 14,410 | 13,903 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.55 |
2025-06-30 | -$0.46 |
2025-03-31 | -$0.50 |
2024-12-31 | -$0.54 |
